Skip to main content
. 2018 Jul 18;103(12):4419–4427. doi: 10.1210/jc.2018-00755

Table 3.

GH Secretion After Somatostatin Withdrawal and Injection of GHRH and GHRP2

Group D/T(−) D/T(+) D/T(+)/A/E2(−) D/T(+)/A/E2(+) ANOVA
Somatostatin withdrawal
 No. of subjects 7 9 9 9
 Mean GH, µg/L 0.74 ± 0.41 0.67 ± 0.24 0.67 ± 0.17 0.79 ± 0.18 0.64
 Maximal GH concentration, µg/L 1.9 ± 0.9 2.1 ± 0.8 1.7 ± 0.3 2.5 ± 0.6 0.65
 *Time of maximum, min 90 ± 12 46 ± 7a 96 ± 13 56 ± 10b 0.004
 Pulsatile GH secretion, µg/L/2 h 8.4 ± 5.1 5.8 ± 2.3 6.2 ± 2.1 6.8 ± 1.4 0.92
GHRH/GHRP2 injection
 No. of subjects 9 9 11 11
 Mean GH, µg/L 5.8 ± 0.8 8.0 ± 1.9 9.7 ± 2.2 9.9 ± 1.7 0.36
 Maximal GH concentration, µg/L 16.1 ± 1.9 19.9 ± 4.1 21.1 ± 3.9 23.6 ± 3.7 0.53
 Time of maximum, min 14.4 ± 1.8 14.4 ± 1.8 19.1 ± 1.6 18.2 ± 1.2c 0.08
 Pulsatile GH secretion µg/L/2 h 33.3 ± 4.1 51.9 ± 11.9 65.1 ± 15.6 62.5 ± 11.5 0.27

Data are shown as the mean ± SEM. Boldface denotes P < 0.05.

Abbreviations: A, anastrozole; D, degarelix; E2(+), 17β−Ε2 addback; E2(−), no 17β− E2 addback; T(+), testosterone addback; T(−), no testosterone addback.

a

T(−) vs T(+) post hoc contrast after ANOVA, P = 0.009.

b

E2(−) vs E2(+) post hoc contrast after ANOVA, P = 0.011.

c

Anastrozole vs no anastrozole post hoc contrast after ANOVA, P = 0.012.